Global index to summarise health risks versus benefit in the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial

被引：0

|

作者：

Howell, A.

机构：

来源：

EJC SUPPLEMENTS | 2005年 / 3卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：98 / 98

页数：1

相关论文

共 50 条

[41] The arimidex, alone or in combination (ATAC) adjuvant breast cancer trial: Baseline endometrial sub-protocol data
Duffy, S
Jackson, TL
EUROPEAN JOURNAL OF CANCER, 2002, 38 : S83 - S83
[42] The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy
Duffy, S
Jackson, TL
Lansdown, M
Philips, K
Wells, M
Pollard, S
Clack, G
Coibion, M
Bianco, AR
HUMAN REPRODUCTION, 2005, 20 (01) : 294 - 301
[43] Clinical trial presentations, agency guidelines, and oncology practice: Findings from the arimidex, tamoxifen, alone or in combination trial
Chlebowski, Rowan T.
CLINICAL BREAST CANCER, 2008, 8 (04) : 343 - 346
[44] Association between prior chemotherapy and the adverse event profile of adjuvant anastrozole and tamoxifen: a retrospective analysis of data from the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trail on behalf of the ATAC Trialists' Group
Coleman, Robert
ANNALS OF ONCOLOGY, 2004, 15 : 64 - 64
[45] Initial adjuvant therapy with anastrozole - early- and late-event data from the arimidex, tamoxifen, alone or in combination (ATAC) trial in the hormone-responsive population
Howell, A.
Forbes, J.
Cuzick, J.
BREAST, 2009, 18 : S51 - S51
[46] The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) Trial in Postmenopausal Women with Early Breast Cancer – Updated Efficacy Results Based on a Median Follow-up of 47 Months
Aman Buzdar
Breast Cancer Research and Treatment, 2003, 77 (3) : 295 - 295
[47] Fewer gynaecological adverse events (AEs), gynaecological interventions, endometrial changes and abnormalities with anastrozole than with tamoxifen: findings from the ATAC ('Arimidex', Tarmoxifen, Alone or in Combination) trial
Distler, W.
BREAST, 2007, 16 : S45 - S46
[48] Using anastrozole as initial adjuvant treatment prevents early recurrences and reduces adverse events: Updated data from the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial.
Houghton, J
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 24S - 24S
[49] The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial in postmenopausal women with early breast cancer - updated efficacy results based on a median follow-up of 5 years
Howell, A
BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S7 - S7
[50] Aromatase inhibitors in prevention - Data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second international breast cancer intervention study)
Cuzick, J
TUMOR PREVENTION AND GENETICS, 2003, 163 : 96 - 103

← 1 2 3 4 5 →